TargetMol

(5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one

Product Code:
 
TAR-T2S1702
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2S1702-1mg1mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-2mg2mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-5mg5mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-1mL1 mL * 10 mM (in DMSO)£157.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-10mg10mg£204.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-25mg25mg£297.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-50mg50mg£409.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2S1702-100mg100mg£531.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
1. 5-Hydroxy-1, 7-diphenyl-6-hepten-3-one has antioxidant activity.
CAS:
87095-74-7
Formula:
C19H20O2
Molecular Weight:
280.367
Pathway:
oxidation-reduction
Purity:
0.999
SMILES:
O[C@H](CC(=O)CCc1ccccc1)C=Cc1ccccc1
Target:
Antioxidant

References

1. Habsah M , Ali N H L M , Sukari M A , et al. The Antioxidative Components from Alpinia nutans[J]. Pharmaceutical Biology, 2003, 41(1):7-9.